| Compositions and methods for genetically modifying ciita in a cell |
2023-7-19 |
2023-7-31 |
|
| Compositions and methods for reducing hla-a in a cell |
2023-7-19 |
2023-8-09 |
|
| Polynucleotides, Compositions, and Methods for Genome Editing Involving … |
2023-7-07 |
2023-8-18 |
|
| Compositions and methods for reducing mhc class ii in a cell |
2023-7-05 |
2023-8-18 |
|
| Stabilized Nucleic Acids Encoding Messenger Ribonucleic Acid (mRNA) |
2023-5-01 |
2023-8-31 |
|
| Lipid Nanoparticle Formulations for CRISPR/CAS Components |
2023-3-13 |
2023-6-27 |
|
| Compositions and methods for immunooncology |
2023-2-27 |
2023-4-13 |
|
| Compositions and methods for treating alpha-1 antitrypsin deficiency |
2023-2-24 |
2023-5-30 |
|
| Crispr-mediated transgene insertion in neonatal cells |
2023-2-02 |
2023-8-10 |
|
| Compositions and methods for treatment of hemoglobinopathies |
2023-1-06 |
2023-4-11 |
|
| Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis |
2022-12-09 |
2023-8-17 |
|
| Modified guide rnas for gene editing |
2022-11-02 |
2023-5-11 |
|
| Cd38 compositions and methods for immunotherapy |
2022-11-02 |
2023-5-11 |
|
| Polynucleotides, compositions, and methods for genome editing |
2022-11-02 |
2023-6-08 |
|
| Methods of in Vitro Cell Delivery |
2022-10-27 |
2023-6-15 |
|
| Compositions and methods for treating alpha-1 antitrypsin deficiency |
2022-10-14 |
2023-4-20 |
|
| Modified Guide RNAs |
2022-9-01 |
2023-9-14 |
|
| Compositions and methods for kallikrein (klkb1) gene editing |
2022-8-26 |
2022-9-09 |
|
| Programmed cell death protein 1 (pd1) compositions and methods for cell-based … |
2022-8-23 |
2023-3-02 |
|
| Compositions and Methods for Kallikrein (KLKB1) Gene Editing |
2022-8-05 |
2023-9-21 |
|
| Modified guide RNA for gene editing |
2022-7-07 |
2022-8-30 |
|
| Methods for in vivo editing of a liver gene |
2022-6-22 |
2022-12-29 |
|
| Modified guide rnas comprising an internal linker for gene editing |
2022-6-09 |
2023-5-01 |
|
| Methods and Compositions for Directed Genome Editing |
2022-5-03 |
2023-3-09 |
|
| Compositions and methods for the treatment of hemoglobinopathies |
2022-4-19 |
2022-5-12 |
|
| Inhibitors of dna-dependent protein kinase and compositions and uses thereof |
2022-4-15 |
2023-3-01 |
|
| Lipid nanoparticle compositions |
2022-4-15 |
2023-3-01 |
|
| Lipid nanoparticle compositions |
2022-4-15 |
2023-3-01 |
|
| Lymphocyte activation gene 3 (lag3) compositions and methods for immunotherapy |
2022-2-07 |
2022-9-22 |
|
| T-cell immunoglobulin and mucin domain 3 (tim3) compositions and methods for … |
2022-2-07 |
2022-11-24 |
|
| Natural killer cell receptor 2b4 compositions and methods for immunotherapy |
2022-2-07 |
2022-8-11 |
|
| Engineered t cells |
2021-12-29 |
2022-7-07 |
|
| Compositions and methods for genetically modifying CIITA in cells |
2021-12-22 |
2023-9-19 |
|
| Compositions and methods for reducing HLA-A in cells |
2021-12-22 |
2023-9-12 |
|
| Compositions and methods for reducing MHC class II in cells |
2021-12-10 |
2023-9-22 |
|
| Ionizable amine lipids and lipid nanoparticles |
2021-11-03 |
2022-1-17 |
|
| Compositions and methods for ttr gene editing and treatment of attr amyloidosis … |
2021-10-28 |
2021-11-19 |
|
| Compositions and Methods Comprising a Ttr Guide RNA and a Polynucleotide … |
2021-10-28 |
2021-11-19 |
|
| Polynucleotides, compositions and methods for the expression of polypeptides |
2021-10-27 |
2021-11-19 |
|
| Modified amine lipids |
2021-7-02 |
2021-10-29 |
|
| Compositions and Methods for Treating Alpha-1 Antitrypsin Deficiency |
2021-5-18 |
2021-8-19 |
|
| Compositions and methods for the expression of transgenes from an albumin locus |
2021-5-18 |
2021-8-19 |
|
| Nucleic Acid Constructs and Methods of Use |
2021-5-18 |
2021-8-19 |
|
| Compositions and methods to express factor ix |
2021-5-18 |
2021-8-19 |
|
| Immunotherapy compositions and methods |
2021-5-13 |
2021-6-10 |
|
| Ionizable amine lipids |
2021-4-30 |
2021-7-30 |
|
| Methods and compositions for ocular cell therapy |
2021-4-26 |
2023-1-31 |
|
| Compositions and methods for lactate dehydrogenase (ldha) gene editing |
2021-4-23 |
2021-6-10 |
|
| Methods and Compositions for Ocular Cell Therapy |
2021-4-23 |
2021-5-10 |
|
| Compositions and methods for editing the hydroxy acid oxidase 1 (hao1) gene to … |
2021-2-26 |
2021-4-08 |
|
| Modified rna guidelines for gene editing |
2021-1-06 |
2021-1-18 |
|
| Polynucleotides, compositions and methods for genome editing |
2020-4-27 |
2020-5-15 |
|
| COMPOSITIONS AND METHODS FOR EDITING TTR GENE AND TREATMENT ATTR AMYLOIDOSIS … |
2020-3-27 |
2022-6-28 |
|
| Formulations |
2020-3-24 |
2020-5-31 |
|
| METHODS AND COMPOSITIONS FOR EYE CELL THERAPY |
2019-10-25 |
2021-10-13 |
|
| METHODS AND COMPOSITIONS FOR EYE CELL THERAPY |
2019-10-23 |
2021-6-16 |
|
| Composition and methods for immunooncology |
2019-9-20 |
2020-7-06 |
|
| Compositions and methods for immunooncology |
2019-6-10 |
2020-10-01 |
|
| MODIFIED GUIDELINES FROM RNA FOR GENE EDITING |
2019-6-07 |
2021-1-27 |
|
| Compositions and methods for treating diseases associated with trinucleotide … |
2018-11-19 |
2019-4-30 |
|
| in vitro method of administering mrna using lipid nanoparticles |
2018-9-28 |
2020-10-20 |
|
| Methods for the treatment of disease with gene editing systems |
2018-6-28 |
2020-5-07 |
|
| Improved methods for analyzing edited dna |
2017-9-14 |
2018-3-22 |
|
| FORMULATIONS OF LIPID NANOPARTICLES FOR CAS / CRISPR COMPONENTS |
2017-3-30 |
2018-8-22 |
|
| Methods and compositions for gene editing |
2017-3-13 |
2017-9-21 |
|
| 用于减少细胞中ii类mhc的组合物和方法 |
2021-12-10 |
2023-9-22 |
|
| Métodos e composições para terapia celular ocular |
2019-10-25 |
2021-10-13 |
|